Indications and uses
• helps prevent sunburn
CLARINS Skin Illusion SPF 10 Natural Radiance Foundation Tint 112
- Manufacturer
- Laboratoires Clarins S.A.
- Effective date
- 2019-12-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:49:38
Label at a glance#
ProductCLARINS Skin Illusion SPF 10 Natural Radiance Foundation Tint 112
Active ingredientTITANIUM DIOXIDE
Label structure10 sections
Dosage and administration
• apply liberally 15 minutes before sun exposure • apply to all skin exposed to the sun • children under 6 months: Ask a doctor • reapply at least every 2 hours • use a water resistant sunscreen if swimming or sweating.
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient
TITANIUM DIOXIDE 1.89%
Purpose
Sunscreen
Uses
• helps prevent sunburn
Warnings:
Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. For external use only.
Do not use
• on damaged or broken skin
When using this product
• keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if
• rash occurs.
Keep out of reach of children.
If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions:
• apply liberally 15 minutes before sun exposure
• apply to all skin exposed to the sun
• children under 6 months: Ask a doctor
• reapply at least every 2 hours
• use a water resistant sunscreen if swimming or sweating.
Inactive ingredients
AQUA/WATER/EAU . CYCLOPENTASILOXANE . ISONONYL ISONONANOATE . BUTYLENE GLYCOL . ALCOHOL . HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER . PEG/PPG-20/15 DIMETHICONE . NYLON-12 . MAGNESIUM SULFATE . POLYGLYCERYL-3 DIISOSTEARATE . SILICA . DISTEARDIMONIUM HECTORITE . POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE . PEG-10
DIMETHICONE . PARFUM/ FRAGRANCE . GLYCERIN . ALUMINUM HYDROXIDE . STEARIC ACID . DISODIUM STEAROYL GLUTAMATE . ETHYLHEXYLGLYCERIN . METHYLPROPANEDIOL . MICA . DISODIUM EDTA . HYDROXYETHYL UREA . SORBIC ACID . HYDRATED SILICA . ASPARAGOPSIS ARMATA EXTRACT . CAMELLIA SINENSIS LEAF EXTRACT . PHENOXYETHANOL . LAPSANA COMMUNIS FLOWER/LEAF/
STEM EXTRACT . ALGIN . ACACIA SENEGAL GUM . OPAL POWDER . CARBOMER. ± / MAY CONTAIN/PEUT CONTENIR: CI 77891/ TITANIUM DIOXIDE . CI 77491/CI 77492/CI 77499/ IRON OXIDES. [M2067A]
Other information:
• protect this product from excessive heat and direct sun.
A light-reflecting, hydrating foundation that perfectly combines mineral and plant ingredients to create a naturally radiant complexion. The unique blend of ingredients continuously hydrates and protects the skin resulting in an incredibly comfortable, beautifully radiant and perfectly even complexion.
Satin finish - Medium coverage - All skin types.
Non-comedogenic. Dermatologist tested. Oil-free.
Questions or comments?
Call 1-866-252-7467 Monday-Friday, 8 a.m. to 5 p.m.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
CLARINS PARIS 112 Skin Illusion Mineral and Plant Extracts Teint Lumiere Effet Naturel SPF 10 Titanium Dioxide - Sunscreen Natural Radiance Foundation e30 mL 1.1 Oz. Net Wt. 18M CLARINS-PARIS 92200 Neuilly 95300 Pontoise - France Made in France
Product Labels
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 5 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 5 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 5 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 5 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 5 | |
| ASPARAGOPSIS ARMATA | INACTIVE INGREDIENT | 2936KN6I1G | 5 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 5 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 5 | |
| DISODIUM STEAROYL GLUTAMATE | INACTIVE INGREDIENT | 45ASM2L11M | 5 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 5 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 5 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 5 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 5 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 5 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 5 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 5 | |
| HYDRATED SILICA | INACTIVE INGREDIENT | Y6O7T4G8P9 | 5 | |
| HYDROXYETHYL UREA | INACTIVE INGREDIENT | MBQ7DDQ7AR | 5 | |
| ISONONYL ISONONANOATE | INACTIVE INGREDIENT | S4V5BS6GCX | 5 | |
| LAPSANA COMMUNIS FLOWERING TOP | INACTIVE INGREDIENT | T9B77O7PZA | 5 | |
| MAGNESIUM SULFATE | INACTIVE INGREDIENT | DE08037SAB | 5 | |
| METHYLPROPANEDIOL | INACTIVE INGREDIENT | N8F53B3R4R | 5 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 5 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 5 | |
| PEG/PPG-20/15 DIMETHICONE | INACTIVE INGREDIENT | 06R6X77P9C | 5 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 5 | |
| POLYGLYCERYL-3 DIISOSTEARATE | INACTIVE INGREDIENT | 46P231IQV8 | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 5 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 5 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Products#
Every source-derived product name is available through these pages.
- CLARINS Skin Illusion SPF 10 Natural Radiance Foundation Tint 112
- TITANIUM DIOXIDE
- WATER
- CYCLOMETHICONE 5
- ISONONYL ISONONANOATE
- BUTYLENE GLYCOL
- ALCOHOL
- PEG/PPG-20/15 DIMETHICONE
- NYLON-12
- MAGNESIUM SULFATE, UNSPECIFIED FORM
- POLYGLYCERYL-3 DIISOSTEARATE
- SILICON DIOXIDE
- GLYCERIN
- ALUMINUM HYDROXIDE
- STEARIC ACID
- DISODIUM STEAROYL GLUTAMATE
- ETHYLHEXYLGLYCERIN
- METHYLPROPANEDIOL
- MICA
- EDETATE DISODIUM
- HYDROXYETHYL UREA
- SORBIC ACID
- HYDRATED SILICA
- ASPARAGOPSIS ARMATA
- GREEN TEA LEAF
- PHENOXYETHANOL
- LAPSANA COMMUNIS FLOWERING TOP
- ACACIA
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58668-2721 | 58668-2721-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE / ORAL | 14 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, EXTENDED RELEASE / ORAL | 15 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | SOLUTION/ DROPS / OPHTHALMIC | 0.2 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, COATED / ORAL | 156 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| ACACIA | ACACIA | 5C5403N26O | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | DE08037SAB | TABLET, FILM COATED / ORAL | 14 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / NASAL | 1 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, COATED / ORAL | 0.11 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CAPSULE / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / ORAL | 432 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INFILTRATION | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / OPHTHALMIC | 0.05 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, EXTENDED RELEASE / ORAL | 8 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / ORAL | 70 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY / RESPIRATORY (INHALATION) | 0.05 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d07bebb5-4824-97e6-e053-2a95a90ad77f | 7a07b298-da8d-4722-8773-5342af6dedf7 | 2021-11-10 | Warnings | 7a07b298-da8d-4722-8773-5342af6dedf7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.